openPR Logo

Press Releases from bitop AG (5 total)

bitop is exhibitor at the in-cosmetics

At this year’s in-cosmetics show, taking place on April 1-3 in Hamburg, Germany, the cosmetics department of the extremolyte specialist bitop will showcase for the first time its product portfolio at booth 1K50. Focus of the exhibition at the in-cosmetics is the presentation of bitop’s broad extremolyte product portfolio – including the well-known Ectoin® - but also of new ingredients with innovative properties. Innovative ingredients that fulfil customer

bitop strengthens its sales activities for the Personal Care Industry

bitop today announced that it has recently gained DKSH International Ltd. and C.H. Erbslöh KG Chemiehandel as distribution partners to strengthen its business with cosmetic active ingredients. By means of these cooperations, bitop can offer its new active cosmetic ingredients Glycoin® natural and 28Extremoin® to manufacturers of the personal care industry in Asia and the most important European countries. Furthermore bitop is able to strengthen its business with its established

bitop AG receives Frost & Sullivan’s 2013 New Product Innovation Award for its …

The Ectoin® Allergy product line is expected to revolutionize the way allergies are treated. Witten - June 18th 2013 – Frost & Sullivan, a global research organization of 1,800 analysts and consultants, monitors more than 300 industries and 250,000 companies to determine how best-in-class companies worldwide manage growth, innovation and leadership. Based on the findings of this research, Frost & Sullivan grants the 2013 European New Product Innovation Award in Extremolytes

bitop AG and JGL d.d. Croatia signed License and Supply Agreement for Ectoin® A …

bitop AG today announced that it has recently entered into an exclusive license and supply agreement with JADRAN-GALENSKI LABORATORIJ d.d. (JGL d.d.) for bitop’s Ectoin® Allergy Nasal Spray 2%. Under this agreement, JGL d.d. will have the right to sell the nasal spray under its Aqua Maris® brand in various countries of the CEE and CIS regions. The agreement is valid for 3 years. The sale of the product with

bitop AG and Alfa Intes signed License and Supply Agreement for Ectoin® Allergy …

bitop AG today announced that it has recently entered into an exclusive license and supply agreement with Alfa Intes Terapeutica Splendore Srl for bitop’s Ectoin® Allergy Eye Drops 2%. Under this agreement, Alfa Intes has the right to sell the eye drops with the name Ectoal in Italy, Vatican City and the republic of San Marino. The agreement is valid for 5 years. The sale of Ectoal has started in

Go To Page:   1 2 3 4 5 6 7 8 9 10